Ketamine during surgery: a new hope for calming cancer Patients' fears?
NCT ID NCT07367542
Summary
This study is testing if giving a low, continuous dose of a drug called esketamine (related to ketamine) during breast cancer surgery can help reduce the anxiety and depression many patients feel around their operation. It will involve about 218 patients and will measure their emotional state, sleep quality, pain, and overall recovery after surgery. The goal is to see if this approach improves patients' emotional well-being and recovery experience.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Medical center of Chinese PLA General Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.